Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Nivolumab drug shows better response rate in metastatic bladder cancer patients

Nivolumab drug shows better response rate in metastatic bladder cancer patients

The National MDS Study aims to identify causes, genetic makeup of fatal blood diseases

The National MDS Study aims to identify causes, genetic makeup of fatal blood diseases

Positive effects of good nutrition linked to child's social behavior, development

Positive effects of good nutrition linked to child's social behavior, development

New article reviews guidelines for folic acid supplementation in pregnancy

New article reviews guidelines for folic acid supplementation in pregnancy

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Globin gene transfer to treat beta-thalassemias shows promise in first clinical trial

Globin gene transfer to treat beta-thalassemias shows promise in first clinical trial

Experimental drug ozanimod moderately effective in treatment of ulcerative colitis

Experimental drug ozanimod moderately effective in treatment of ulcerative colitis

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Researchers discover new function of genes in Fanconi anemia pathway

Researchers discover new function of genes in Fanconi anemia pathway

Musashi-2 protein regulates function, development of blood stem cells

Musashi-2 protein regulates function, development of blood stem cells

Series of routine tests may not be beneficial to patients with age-related disorder

Series of routine tests may not be beneficial to patients with age-related disorder

Scientists use FAN1 knockout mice to refine detailed mechanisms involved in damaged DNA repair

Scientists use FAN1 knockout mice to refine detailed mechanisms involved in damaged DNA repair

Inhalable form of Ambrisentan drug could offer faster-acting treatment option for pulmonary edema

Inhalable form of Ambrisentan drug could offer faster-acting treatment option for pulmonary edema

GHIT Fund invests in two innovative malaria eradication tools

GHIT Fund invests in two innovative malaria eradication tools

Whole genome sequencing of chimpanzee parasite reveals clues about human malaria

Whole genome sequencing of chimpanzee parasite reveals clues about human malaria

Study: Conservative care could be a reasonable choice for selected kidney failure patients

Study: Conservative care could be a reasonable choice for selected kidney failure patients

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Consuming green tea with dietary iron may lessen health benefits of green tea

Consuming green tea with dietary iron may lessen health benefits of green tea

Rutgers' new drug candidate may help fight malaria

Rutgers' new drug candidate may help fight malaria

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.